The Senate Health, Education, Labor and Pensions Committee today held a hearing for Alex Azar, President Trump’s nominee for secretary of Health and Human Services. Azar, former president of Lilly USA and deputy HHS secretary under the George W. Bush administration, faced a number of questions from senators about his ties to the pharmaceutical industry and how he would tackle high drug prices. “I believe I can bring the skills and experiences to the table that can help us address these issues, while still encouraging discovery so Americans have access to high quality care,” Azar said. Trump nominated Azar for HHS secretary earlier this month. Tom Price, M.D., resigned as HHS secretary on Sept. 29. Deputy Secretary Eric Hargan has been serving as acting secretary. Azar will need to testify before the Senate Finance Committee, which has not announced a hearing date, before the full Senate votes on his appointment.
Hospitals and health systems recognize that addressing social determinants of health is central to driving value and advancing overall well-being.
The Aspen Institute recently chose AHA Senior Vice President and Chief Medical Officer Jay Bhatt, D.O., to participate in its Health Innovators Fellowship.
Insights and Analysis
Also in this roundup of hospital and health system leadership changes: Franciscan Missionaries of Our Lady Health System, Baton Rouge, La., selects CEO, and…
The National Center for Healthcare Leadership will present the 2019 Gail L. Warden Leadership Excellence Award to Rodney F. Hochman, M.D., president and CEO of…
To all our hospital and health system leaders: Thank you for encouraging innovation among your teams…nurturing big dreams for our field…and working tirelessly…
AHA’s Leadership Summit will deliver a speaker and topic to engage everyone, from trustee to clinician to CEO.